Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
EMBO J. 2012 Nov 14;31(22):4318-33. doi: 10.1038/emboj.2012.275. Epub 2012 Oct 12.
Cell fate decisions during haematopoiesis are governed by lineage-specific transcription factors, such as RUNX1, SCL/TAL1, FLI1 and C/EBP family members. To gain insight into how these transcription factors regulate the activation of haematopoietic genes during embryonic development, we measured the genome-wide dynamics of transcription factor assembly on their target genes during the RUNX1-dependent transition from haemogenic endothelium (HE) to haematopoietic progenitors. Using a Runx1-/- embryonic stem cell differentiation model expressing an inducible Runx1 gene, we show that in the absence of RUNX1, haematopoietic genes bind SCL/TAL1, FLI1 and C/EBPβ and that this early priming is required for correct temporal expression of the myeloid master regulator PU.1 and its downstream targets. After induction, RUNX1 binds to numerous de novo sites, initiating a local increase in histone acetylation and rapid global alterations in the binding patterns of SCL/TAL1 and FLI1. The acquisition of haematopoietic fate controlled by Runx1 therefore does not represent the establishment of a new regulatory layer on top of a pre-existing HE program but instead entails global reorganization of lineage-specific transcription factor assemblies.
在造血过程中,细胞命运决定受到谱系特异性转录因子的控制,如 RUNX1、SCL/TAL1、FLI1 和 C/EBP 家族成员。为了深入了解这些转录因子如何在胚胎发育过程中调节造血基因的激活,我们测量了转录因子在 RUNX1 依赖性从造血内皮(HE)向造血祖细胞过渡过程中在其靶基因上组装的全基因组动态。使用表达诱导型 Runx1 基因的 Runx1-/-胚胎干细胞分化模型,我们表明在没有 RUNX1 的情况下,造血基因结合 SCL/TAL1、FLI1 和 C/EBPβ,并且这种早期启动对于正确的髓系主调控因子 PU.1 及其下游靶基因的时间表达是必需的。诱导后,RUNX1 结合到许多新的位点,引发组蛋白乙酰化的局部增加和 SCL/TAL1 和 FLI1 结合模式的快速全局改变。因此,由 Runx1 控制的造血命运的获得并不是在预先存在的 HE 程序之上建立新的调控层,而是需要谱系特异性转录因子组装的全局重组。